If you have AMD, you could help this MDFA-funded study.
Many potential drugs enter early-stage development. Only a few treatments will progress to late-stage development. This update details early stage treatments.
Results have now been presented at medical conferences in the USA.
Apellis announces initial results from two phase III studies in geographic atrophy.
MDFA funded researcher Ms Diana Tang is rolling out the Movement, Interaction and Nutrition for Greater Lifestyles in the Elderly – or MINGLE – program.
MDFA funded researcher, Dr Anai Gonzalez Cordero is creating an organoid – essentially a mini organ in a dish – with a macular structure.
MDFA has awarded more than $1 million in research funding to eight promising projects, in the search for a cure for macular diseases.
Celebrating the 10th anniversary of MDFA’s Research Grants Program, this free publication introduces you to the talented researchers your donations have funded since 2011.
Faye Grant included MDFA in her Will. Her bequest is now funding vital, innovative research into macular disease through the Grant Family Fund.
A new chemical compound could become a future tool against retinal vascular disease. The finding is the result of a pre-clinical study, led by UNSW researchers.
Faricimab has taken one step closer towards clinics in Australia.
The latest research relevant to optometrists and other health professionals
Participate in new intervention designed to improve glaucoma and diabetic eye care.
The US FDA recently approved two treatments: Susvimo® and Vabysmo®.
Volunteers with AMD sought to build a new computerised instrument.
Read the latest from CERA researchers Dr Zhichao Wu, Himeesh Kumar and Prof Robyn Guymer.
MDFA’s summary of the past 12 months’ research into macular disease.
If you have AMD, you could help this MDFA-funded study.
Many potential drugs enter early-stage development. Only a few treatments will progress to late-stage development. This update details early stage treatments.